Involvement of endothelin in morphine tolerance in neuroblastoma (SH-SY5Y) cells

Experimental Biology and Medicine

Volumn 231, Issue 6, 2006, Pages 1152-1156

  Bhalla, Shaifali ^a   Ciaccio, Natalie ^a   Zaijie, Jim Wang ^a   Gulati, Anil ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

BMS182874 (5 dimethylamino N 3,4 dimethyl 5 isoxazolyd 1 naphthalenesulfonamide); Endothelin; ETA receptors; Morphine; SH SY5Y cells; Tolerance

Indexed keywords

5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; ENDOTHELIN; ENDOTHELIN A RECEPTOR ANTAGONIST; G PROTEIN COUPLED RECEPTOR; MORPHINE; OPIATE RECEPTOR;

ANTINOCICEPTION; BINDING ASSAY; CELL LINE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MORPHINE TOLERANCE; NEUROBLASTOMA; SENSITIZATION;

ANALGESICS, OPIOID; CELL LINE, TUMOR; DANSYL COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG TOLERANCE; ENDOTHELIN-1; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MORPHINE; NEUROBLASTOMA; RECEPTOR, ENDOTHELIN A; RECEPTORS, G-PROTEIN-COUPLED;

ANIMALIA;

EID: 33744914047     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343, 2001.
2. Narita M, Funada M, Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89:1-15, 2001.
3. Collin E, Cesselin F. Neurobiological mechanisms of opioid tolerance and dependence. Clin Neuropharmacol 14:465-488, 1991.
4. Chakrabarti S, Oppermann M, Gintzler AR. Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: a novel mechanism for modulating cell signaling. Proc Natl Acad Sci U S A 98:4209-4214, 2001.
5. Nishikawa K, Tanobe K, Hinohara H, Okamoto T, Saito S, Goto F. [Molecular mechanism of morphine tolerance and biological approaches to resolve tolerance]. Masui 53:502-507, 2004.
6. Takemori AE, Loh HH, Lee NM. Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice. Eur J Pharmacol 221:223-226, 1992.
7. Wen HL, Ho WK. Suppression of withdrawal symptoms by dynorphin in heroin addicts. Eur J Pharmacol 82:183-186, 1982.
8. Bhargava HN. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. Pharmacol Rev 46:293-324, 1994.
9. Bhalla S, Matwyshyn G, Gulati A. Potentiation of morphine analgesia by BQ123, an endothelin antagonist. Peptides 23:1837-1845, 2002.
10. Bhalla S, Matwyshyn G, Gulati A. Endothelin receptor antagonists restore morphine analgesia in morphine tolerant rats. Peptides 24:553-561, 2003.
11. Wang Z, Sadee W. Tolerance to morphine at the mu-opioid receptor differentially induced by cAMP-dependent protein kinase activation and morphine. Eur J Pharmacol 389:165-171, 2000.
12. 2+ and inositol 1,4,5-trisphosphate mass in a human neuroblastoma cell line, SH-SY5Y. Biochem J 265:555-562, 1990.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951.
14. Elliott J, Guo L, Traynor JR. Tolerance to mu-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5′-O-(3- [35S]-thio)triphosphate binding. Br J Pharmacol 121:1422-1428, 1997.